New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance ...

From weight loss injections to a newly approved pill, GLP-1 medications are everywhere– but many people are still unclear on ...

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...